Sponsor pipeline

Rempex (a wholly owned subsidiary of Melinta Therapeutics, LLC) clinical trial pipeline

Get alerts when Rempex (a wholly owned subsidiary of Melinta Therapeutics, LLC)'s trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

Active trials by phase

Phase 2
1

Active trials

NCT IDTitleConditionStatusUpdated
Phase 2
NCT06672978 A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of… Acute Pyelonephritis Active, Not Recruiting 2026-09-10
Get alerts when Rempex (a wholly owned subsidiary of Melinta Therapeutics, LLC)'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free